Araştırma Makalesi

Efficacy of Taxifolin in The Prevention of Renal Injury Due to Liver Ischemia and Reperfusion

Cilt: 6 Sayı: 3 31 Aralık 2023
PDF İndir
TR EN

Efficacy of Taxifolin in The Prevention of Renal Injury Due to Liver Ischemia and Reperfusion

Abstract

Aim: During surgical procedures such as liver resection and transplantation, ischemia/reperfusion (I/R) injury and related complications may occur at a rate of approximately 10%. Our study, we planned to investigate histologically and biochemically the efficacy of Taxifolin in the prevention of renal tissue damage in liver ischemia reperfusion. Methods: A total of 28 Wistar Albino rats with an average age of 8-10 weeks and weights of 250-300 grams were used in our study. Group 1 (n=7): control group, Group 2 (n=7): Taxifolin group; Taxifolin was administered orally at a dose of 50 mg/kg for 3 weeks, Group 3 (n=7): Liver I/R group, 30 minutes ischemia and 120 minutes reperfusion was performed. Group 4 (n=7): Taxifolin+Liver I/R group. Results: Kidney tissues of the liver I/R group showed atrophy, degeneration of tubule epithelium and increased TNF-α expression. In addition, deterioration in renal function tests was also monitored in this group. In the Taxifolin+Liver I/R group, a significant difference was observed on both histologic and biochemical basis compared to the Liver I/R group and a positive effect was observed (p<0.05). Outcome: As a consequence of hepatic ischemia and reperfusion, impairment in the function and histological appearance of renal tissues was observed and Taxifolin was monitored to be effective in eliminating these adverse effects.

Keywords

Kaynakça

  1. 1.Fondevila C, Busuttil Rw, Kupiec-Weglinski Jw. Hepatic Ischemia/Reperfusion Injury A Fresh Look. Exp Mol Pathol. 2003; 74 (2): 86-93. Https://Doi.Org/10.1016/S0014-4800(03)00008-X
  2. 2.Zhai Y, Petrowsky H, Hong Jc, Et Al. Ischaemia Reperfusion Injury In Liver Transplantation From Bench To Bedside. Nat Rev Gastroenterol Hepatol. 2013; 10 (2): 79-89. Https://Doi.Org/10.1038/Nrgastro.2012.225
  3. 3. Varadarajan R, Golden-Mason L, Young L, Et Al. Nitric Oxide In Early Ischaemia Reperfusion Injury During Human Orthotopic Liver Transplantation. Transplantation. 2004; 78(2): 250–6. Https://Doi.Org/10.1097/01.Tp.0000128188.45553.8c
  4. 4.Ugarte-Uribe B, García-Sáez Aj. Membranes In Motion: Mitochondrial Dynamics And Their Role In Apoptosis. Biol Chem. 2014; 395 (3):297-311. Https://Doi.Org/10.1515/Hsz-2013-0234
  5. 5.Zhang W, Chen C, Wang J, Et Al. Mitophagy In Cardiomyocytes And In Platelets: A Major Mechanism Of Cardioprotection Against Ischemia/Reperfusion Injury. Physiology. 2018; 33 (2): 86-98. Https://Doi.Org/10.1152/Physiol.00030.2017
  6. 6. Salaritabar A, Darvishi B, Hadjiakhoondi F, Et Al. Therapeutic Potential Of Flavonoids In Inflammatory Bowel Disease: A Comprehensive Review. World J. Gastroenterol. 2017; 23(28): 5097-114. https://doi.org/ 10.3748/Wjg.V23I28.5097
  7. 7. Yang P, Xu F, Li Hf, Et Al. Detection Of 191 Taxifolin Metabolites And Their Distribution In Rats Using Hplc-Esi-It-Tof-Msn. Molecules. 2016;21(9): 1209. Https://Doi.Org/10.3390/Molecules21091209
  8. 8.Weidmann Ae. Dihydroquercetin: More Than Just An Impurity? Eur. J. Pharmacol. 2012;684(1-3): 19–26. Https://Doi.Org/10.1016/J.Ejphar.2012.03.035

Ayrıntılar

Birincil Dil

İngilizce

Konular

Genel Cerrahi , Patoloji

Bölüm

Araştırma Makalesi

Yayımlanma Tarihi

31 Aralık 2023

Gönderilme Tarihi

5 Ekim 2023

Kabul Tarihi

25 Aralık 2023

Yayımlandığı Sayı

Yıl 2023 Cilt: 6 Sayı: 3

Kaynak Göster

APA
Ülger, B. V., Aşır, F., Varlı, M., Gündüz, E., & Durgun, H. M. (2023). Efficacy of Taxifolin in The Prevention of Renal Injury Due to Liver Ischemia and Reperfusion. Journal of Cukurova Anesthesia and Surgical Sciences, 6(3), 503-507. https://doi.org/10.36516/jocass.1371823
https://dergipark.org.tr/tr/download/journal-file/11303